Two chemists who founded Sanifit: “Biotech entrepreneurship isn’t a sprint. It’s an ultram... 17/12/2021 Healthcare Rare diseases Innovative drugs Two chemists, when they had barely turned 25, set up a spin-off of the University of the Balearic Islands that has just... AseBio
ORYZON at ASH-2021: iadademstat 36-month ALICE data demonstrate robust efficacy in combina... 13/12/2021 Healthcare Robust efficacy - ORR 78%, of which 62% are CR/CRi 77% of CR/CRi lasting more than 6 months Longest remission beyond 1... Partners - Oryzon Genomics
Report | RNA and elite controllers: two keys to fighting HIV 01/12/2021 Healthcare The Covid-19 pandemic seems to have opened up a new door to find a treatment for the virus that causes AIDS. We spoke... AseBio
Oncoheroes Biociences out-licences volasertib to US Notable Labs for adult cancers 18/11/2021 Healthcare The company, headquartered in Boston (United States), centralises the drug discovery activity in its Lab at the... Partners - Parc Científic de Barcelona
BCN Health Booster accelerator kicks off with eleven business projects in health innovatio... 25/11/2021 Healthcare Five spin-offs and six start-ups comprise the first generation of companies accelerated at the BCN Health Booster, an... Partners - Parc Científic de Barcelona
BCN HEALTH publishes a study evaluating the productivity losses associated to colorectal c... 30/11/2021 Healthcare The company conducted an analysis of the productivity losses associated to premature mortality from colorectal cancer in... Partners - BCN Health
Farmaprojects opens a GMP laboratory for quality control and release of medicines in the... 23/11/2021 Healthcare Services Farmaprojects , a company specialising in the supply of generic pharmaceutical specialities, has opened a GMP-Certified... Partners - Parc Científic de Barcelona
ORYZON enrolls first patient in EVOLUTION, a Phase IIb clinical trial with vafidemstat in ... 17/11/2021 Healthcare Primary objectives: to assess the effect of vafidemstat to address negative and cognitive symptoms in schizophrenia... Partners - Oryzon Genomics
ORYZON publishes paper in ACS Pharmacology & Translational Science supporting best-in-cla... 15/11/2021 Healthcare Iadademstat consistently stronger in viability reduction in AML & SCLC cells Superior target engagement at low... Partners - Oryzon Genomics
IUL presents IPEAK® EUROPIUM, a new lateral flow reader for fluorescence labeled lateral ... 04/11/2021 Healthcare IUL presents a new fluorescence lateral flow reader in the framework of the Advanced Lateral Flow Conference in San... Partners
